Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)

HNX:DP3 Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,894	13,706	5,375	21,106	24,727	40,918
Short-Term Investments	364,500	327,987	301,000	185,378	137,000	120,000
Cash & Short-Term Investments	366,394	341,693	306,375	206,484	161,727	160,918
Cash Growth	23.85%	11.53%	48.38%	27.67%	0.50%	0.88%
Accounts Receivable	46,555	34,817	17,061	26,898	20,857	23,940
Other Receivables	2,160	4,539	5,857	1,758	318.51	1,988
Receivables	48,715	39,356	22,918	28,656	21,175	25,928
Inventory	54,356	43,925	52,332	69,835	67,159	56,385
Prepaid Expenses	204.28	222.42	247.03	49.57	334.52	48.83
Other Current Assets	5,685	8,129	1,880	5,161	5,050	11,531
Total Current Assets	475,354	433,326	383,752	310,186	255,446	254,811
Property, Plant & Equipment	118,277	119,745	131,247	154,414	145,838	142,492
Other Intangible Assets	20,181	20,201	20,281	6,514	6,594	5,814
Other Long-Term Assets	34,790	34,504	35,346	36,755	37,626	38,242
Total Assets	648,603	607,777	570,626	507,868	445,504	441,359
Accounts Payable	19,625	7,642	15,695	18,474	19,499	23,880
Accrued Expenses	57,189	63,340	58,681	50,742	44,398	41,568
Short-Term Debt	17,836	-	6,800	5,230	3,528	5,378
Current Income Taxes Payable	6,031	13,243	14,898	10,594	8,084	12,546
Other Current Liabilities	5,176	4,671	5,105	5,378	3,746	11,539
Total Current Liabilities	105,858	88,896	101,179	90,418	79,254	94,911
Long-Term Debt	-	-	975	-	-	-
Total Liabilities	105,858	88,896	102,154	90,418	79,254	94,911
Common Stock	214,999	214,999	214,999	86,000	86,000	86,000
Additional Paid-In Capital	-	-	-	97,659	97,659	97,659
Retained Earnings	327,746	303,881	253,473	233,791	182,591	162,789
Shareholders' Equity	542,745	518,881	468,472	417,450	366,250	346,448
Total Liabilities & Equity	648,603	607,777	570,626	507,868	445,504	441,359
Total Debt	17,836	-	7,775	5,230	3,528	5,378
Net Cash (Debt)	348,558	341,693	298,600	201,254	158,199	155,540
Net Cash Growth	19.69%	14.43%	48.37%	27.21%	1.71%	2.97%
Net Cash Per Share	16212.95	15892.74	13888.41	8892.41	7358.34	7234.49
Filing Date Shares Outstanding	21.5	21.5	21.5	21.5	21.5	22.63
Total Common Shares Outstanding	21.5	21.5	21.5	21.5	21.5	22.63
Working Capital	369,497	344,430	282,572	219,768	176,192	159,900
Book Value Per Share	25244.03	24134.06	21789.47	19416.28	17034.87	15308.18
Tangible Book Value	522,563	498,679	448,191	410,936	359,656	340,634
Tangible Book Value Per Share	24305.35	23194.45	20846.14	19113.30	16728.17	15051.29
Buildings	128,321	126,884	-	-	-	-
Machinery	109,367	109,367	-	-	-	-
Construction In Progress	120	120	401.11	14,390	5,436	65,364

Source: S&P Global Market Intelligence. Standard template. Financial Sources.